Rho Ventures V, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rho Ventures V, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rho Ventures V, L.P.. Rho Ventures V, L.P. is 10% Owner in MiddleBrook Pharmaceuticals, Inc. ($AVNC) and 10% Owner in ReachLocal Inc ($RLOC) and 10% Owner in NephroGenex, Inc. ($NRX) and Director in NephroGenex, Inc. ($NRX).
Latest Insider Trading Transactions of Rho Ventures V, L.P.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVNC, NRX, RLOC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 9.90 | 20,941 | 207,339 | 1,052,966 | 1.1 M to 1.1 M (-1.95 %) |
Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 10.54 | 164,919 | 1,738,065 | 1,073,907 | 1.2 M to 1.1 M (-13.31 %) |
Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 10.83 | 88,000 | 953,207 | 1,238,826 | 1.3 M to 1.2 M (-6.63 %) |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 0 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 0 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 106,697 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 1,215,268 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 0 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 0 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 494,447 | 0 | 0 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 5,631,531 | 0 | 0 | |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Grant | A | 0.00 | 180,997 | 0 | 1,326,826 | 1.1 M to 1.3 M (+15.80 %) |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Buy | C | 0.00 | 203,374 | 0 | 1,145,829 | 942.5 K to 1.1 M (+21.58 %) |
Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Buy | C | 0.00 | 942,455 | 0 | 942,455 | 0 to 942.5 K |
Nov 30 2012 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Sell | S | 11.16 | 275,000 | 3,069,468 | 2,756,966 | 3 M to 2.8 M (-9.07 %) |
Aug 08 2012 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Sell | S | 12.84 | 50,000 | 642,070 | 3,031,966 | 3.1 M to 3 M (-1.62 %) |
Aug 08 2012 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Sell | S | 12.81 | 181,707 | 2,328,484 | 3,081,966 | 3.3 M to 3.1 M (-5.57 %) |
Aug 08 2012 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Sell | S | 12.78 | 68,293 | 872,771 | 3,263,673 | 3.3 M to 3.3 M (-2.05 %) |
May 25 2010 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,276,176 | 0 | 0 | |
May 25 2010 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Buy | P | 13.00 | 307,692 | 3,999,996 | 3,331,966 | 3 M to 3.3 M (+10.17 %) |
May 25 2010 | RLOC | ReachLocal Inc | Rho Ventures V, L.P. | 10% Owner | Buy | C | 0.00 | 2,374,758 | 0 | 3,024,274 | 649.5 K to 3 M (+365.62 %) |
Apr 16 2007 | AVNC | MiddleBrook Pharma ... | Rho Ventures V, L.P. | 10% Owner | Option Exercise | P | 2.27 | 900,000 | 2,043,000 | 900,000 | |
Apr 16 2007 | AVNC | MiddleBrook Pharma ... | Rho Ventures V, L.P. | 10% Owner | Buy | P | 2.36 | 1,200,000 | 2,836,440 | 4,452,478 | 3.3 M to 4.5 M (+36.89 %) |
Page: 1